vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.
Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $85.1M, roughly 1.7× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -2.3%, a 25.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 9.1%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-7.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 8.3%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”
FDMT vs PRPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $140.7M |
| Net Profit | $19.4M | $-3.2M |
| Gross Margin | — | 41.9% |
| Operating Margin | 17.3% | -1.6% |
| Net Margin | 22.8% | -2.3% |
| Revenue YoY | 8508900.0% | 9.1% |
| Net Profit YoY | 139.1% | 62.1% |
| EPS (diluted) | $0.43 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $140.7M | ||
| Q3 25 | $90.0K | $118.8M | ||
| Q2 25 | $15.0K | $105.1M | ||
| Q1 25 | $14.0K | $104.2M | ||
| Q4 24 | $1.0K | $129.0M | ||
| Q3 24 | $3.0K | $118.6M | ||
| Q2 24 | $5.0K | $120.3M | ||
| Q1 24 | $28.0K | $120.0M |
| Q4 25 | $19.4M | $-3.2M | ||
| Q3 25 | $-56.9M | $-11.7M | ||
| Q2 25 | $-54.7M | $-17.3M | ||
| Q1 25 | $-48.0M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $-43.8M | $-39.2M | ||
| Q2 24 | $-35.0M | $27.0K | ||
| Q1 24 | $-32.4M | $-50.2M |
| Q4 25 | — | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | — | 39.4% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 34.8% |
| Q4 25 | 17.3% | -1.6% | ||
| Q3 25 | -67983.3% | -10.2% | ||
| Q2 25 | -396373.3% | -13.5% | ||
| Q1 25 | -383007.1% | -13.9% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | -1704400.0% | -39.5% | ||
| Q2 24 | -849120.0% | -12.1% | ||
| Q1 24 | -136200.0% | -19.3% |
| Q4 25 | 22.8% | -2.3% | ||
| Q3 25 | -63195.6% | -9.9% | ||
| Q2 25 | -364386.7% | -16.5% | ||
| Q1 25 | -342657.1% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | -1461433.3% | -33.1% | ||
| Q2 24 | -699060.0% | 0.0% | ||
| Q1 24 | -115717.9% | -41.8% |
| Q4 25 | $0.43 | $0.03 | ||
| Q3 25 | $-1.01 | $0.11 | ||
| Q2 25 | $-0.98 | $0.16 | ||
| Q1 25 | $-0.86 | $0.18 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-0.79 | $0.36 | ||
| Q2 24 | $-0.63 | $0.00 | ||
| Q1 24 | $-0.66 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $24.3M |
| Total DebtLower is stronger | — | $126.7M |
| Stockholders' EquityBook value | $505.7M | $-29.7M |
| Total Assets | $566.7M | $296.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $24.3M | ||
| Q3 25 | $305.1M | $32.4M | ||
| Q2 25 | $293.2M | $34.2M | ||
| Q1 25 | $321.4M | $21.6M | ||
| Q4 24 | $424.9M | $29.0M | ||
| Q3 24 | $501.9M | $23.4M | ||
| Q2 24 | $541.9M | $23.4M | ||
| Q1 24 | $525.9M | $34.5M |
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | — | $50.8M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $505.7M | $-29.7M | ||
| Q3 25 | $369.0M | $-26.9M | ||
| Q2 25 | $420.9M | $-15.6M | ||
| Q1 25 | $469.7M | $1.3M | ||
| Q4 24 | $510.6M | $20.2M | ||
| Q3 24 | $552.9M | $28.0M | ||
| Q2 24 | $588.3M | $66.4M | ||
| Q1 24 | $600.6M | $65.5M |
| Q4 25 | $566.7M | $296.3M | ||
| Q3 25 | $424.0M | $302.1M | ||
| Q2 25 | $473.6M | $303.8M | ||
| Q1 25 | $515.7M | $293.8M | ||
| Q4 24 | $560.4M | $307.8M | ||
| Q3 24 | $604.0M | $309.3M | ||
| Q2 24 | $620.1M | $362.1M | ||
| Q1 24 | $629.9M | $382.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $-5.8M |
| Free Cash FlowOCF − Capex | $28.5M | $-7.8M |
| FCF MarginFCF / Revenue | 33.5% | -5.5% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $-5.8M | ||
| Q3 25 | $-46.5M | $-968.0K | ||
| Q2 25 | $-43.4M | $-4.0M | ||
| Q1 25 | $-47.8M | $-23.1M | ||
| Q4 24 | $-134.6M | $6.8M | ||
| Q3 24 | $-29.4M | $1.1M | ||
| Q2 24 | $-30.2M | $-8.9M | ||
| Q1 24 | $-29.1M | $-16.8M |
| Q4 25 | $28.5M | $-7.8M | ||
| Q3 25 | $-46.6M | $-1.8M | ||
| Q2 25 | $-43.4M | $-7.0M | ||
| Q1 25 | $-48.4M | $-25.3M | ||
| Q4 24 | $-138.4M | $5.7M | ||
| Q3 24 | $-31.2M | $101.0K | ||
| Q2 24 | $-30.6M | $-11.0M | ||
| Q1 24 | $-29.8M | $-19.9M |
| Q4 25 | 33.5% | -5.5% | ||
| Q3 25 | -51765.6% | -1.5% | ||
| Q2 25 | -289620.0% | -6.6% | ||
| Q1 25 | -345635.7% | -24.3% | ||
| Q4 24 | -13837100.0% | 4.4% | ||
| Q3 24 | -1038966.7% | 0.1% | ||
| Q2 24 | -611840.0% | -9.2% | ||
| Q1 24 | -106421.4% | -16.5% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 101.1% | 0.7% | ||
| Q2 25 | 440.0% | 2.8% | ||
| Q1 25 | 4507.1% | 2.2% | ||
| Q4 24 | 378600.0% | 0.8% | ||
| Q3 24 | 59266.7% | 0.9% | ||
| Q2 24 | 6980.0% | 1.7% | ||
| Q1 24 | 2535.7% | 2.5% |
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
